CARE Ratings Limited Schedules Earnings Call to Discuss Q4 & FY26 Financial Results

1 min read     Updated on 07 May 2026, 09:01 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

CARE Ratings Limited has scheduled an earnings conference call on Thursday, May 14, 2026, at 01:30 PM IST to discuss its financial and operational performance for Q4 and FY26. The call will be led by Mr. Mehul Pandya, Managing Director & Group CEO, along with the Senior Management Team. Dial-in access is available for participants across India, the USA, UK, Singapore, and Hong Kong. The announcement was made through a regulatory filing dated May 5, 2026, signed by Company Secretary & Compliance Officer Manoj Kumar CV.

powered bylight_fuzz_icon
39670313

*this image is generated using AI for illustrative purposes only.

CARE Ratings Limited has announced a conference call with analysts and investors to discuss its financial and operational performance for Q4 and FY26. The call is scheduled for Thursday, May 14, 2026, at 01:30 PM IST, covering results for the quarter and year ended March 31, 2026. The announcement was made via a regulatory filing dated May 5, 2026, and the information has also been made available on the company's website at www.careedge.in .

Earnings Call Details

The following table summarises the key details of the scheduled earnings call:

Parameter: Details
Event: Q4 & FY26 Earnings Conference Call
Date: Thursday, May 14, 2026
Time: 01:30 PM IST
Participants: Mr. Mehul Pandya, Managing Director & Group CEO, and Senior Management Team
Pre-Registration: Available via the link provided in the official invite

Dial-In Access Numbers

Participants can join the call using the following dial-in numbers:

Region: Access Number
Primary (India): +91 22 6280 1309 / +91 22 7115 8210
USA (Toll Free): 1 866 746 2133
UK (Toll Free): 0 808 101 1573
Singapore (Toll Free): 800 101 2045
Hong Kong (Toll Free): 800 964 448

RSVP and Contact Information

Investor relations for the event are being managed by Strategic Growth Advisors Pvt. Ltd. Interested participants may contact the following representatives for RSVP and further queries:

The regulatory communication was signed by Manoj Kumar CV, Company Secretary & Compliance Officer, on behalf of CARE Ratings Limited.

Historical Stock Returns for CARE Ratings

1 Day5 Days1 Month6 Months1 Year5 Years
-0.44%-1.76%+8.45%+3.61%+32.84%+214.55%

How might CARE Ratings' FY26 revenue growth compare to peers like ICRA and CRISIL amid evolving credit rating demand in India?

What impact could RBI's regulatory changes to credit rating agencies have on CARE Ratings' business model and fee structures going forward?

Will CARE Ratings provide guidance on expanding its ESG and sustainability rating services, given growing institutional demand in FY27?

CARE Ratings Allots 300 Equity Shares Under ESOP, Grants 18,000 Fresh Stock Options

1 min read     Updated on 05 May 2026, 09:24 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

CARE Ratings' NRC approved the allotment of 300 equity shares under CARE Employee Stock Option Scheme 2020 on May 04, 2026, increasing paid-up share capital from Rs. 30,04,88,630 to Rs. 30,04,91,630. The NRC also granted 18,000 fresh stock options at an exercise price of Rs. 1,590/-, vesting in equal one-third tranches over three years, with a two-year exercise window post-vesting.

powered bylight_fuzz_icon
39484528

*this image is generated using AI for illustrative purposes only.

The Nomination and Remuneration Committee (NRC) of CARE Ratings Limited approved the allotment of 300 equity shares of face value Rs. 10/- each, fully paid up, to employees of the company pursuant to the exercise of their options under CARE Employee Stock Option Scheme 2020. The meeting of the NRC was held on May 04, 2026, commencing at 2:30 PM and concluding at 5:30 PM.

Impact on Paid-Up Share Capital

The allotment of 300 equity shares has resulted in an increase in the company's paid-up share capital. The following table summarises the change:

Metric: Before Allotment After Allotment
Paid-up Share Capital: Rs. 30,04,88,630/- Rs. 30,04,91,630/-
Number of Equity Shares: 3,00,48,863 3,00,49,163
Face Value per Share: Rs. 10/- Rs. 10/-

Grant of Fresh Stock Options

In addition to the share allotment, the NRC also approved the grant of 18,000 stock options to eligible employees under the CARE Employee Stock Option Scheme 2020. The scheme is in compliance with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The key terms and conditions of the options granted are detailed below:

Parameter: Details
No. of Stock Options Granted: 18,000 (Eighteen Thousand)
Equity Shares Covered: 18,000 equity shares of face value Rs. 10/- each
Exercise Price: Rs. 1,590/-
SEBI Regulation Compliance: Yes — SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021
Exercise Period: 2 years from the date of vesting of options

Vesting Schedule

The 18,000 stock options will vest in equal tranches over a period of three years from the date of grant, as outlined below:

  • 1/3rd of options vest on completion of one year from the date of grant
  • 1/3rd of options vest on completion of the second year from the date of grant
  • 1/3rd of options vest on completion of the third year from the date of grant

The information pertaining to the allotment and the grant of stock options has been made available on the company's website at www.careedge.in . The disclosure was made by Manoj Kumar CV, Company Secretary & Compliance Officer of CARE Ratings Limited.

Historical Stock Returns for CARE Ratings

1 Day5 Days1 Month6 Months1 Year5 Years
-0.44%-1.76%+8.45%+3.61%+32.84%+214.55%

How might the exercise price of Rs. 1,590/- for the newly granted options compare to CARE Ratings' stock performance over the three-year vesting period, and what does this signal about management's confidence in future growth?

Could the gradual dilution from ESOP exercises under the 2020 scheme impact CARE Ratings' earnings per share trajectory, and how are institutional investors likely to respond to continued share capital expansion?

As CARE Ratings continues to grant fresh stock options, what retention challenges or talent competition pressures in the credit rating industry might be driving the need for equity-based compensation?

More News on CARE Ratings

1 Year Returns:+32.84%